An approach to acute respiratory infection in children.
D000328:Adult; D000667:Ampicillin / Q000009:adverse effects / Q000627:therapeutic use*; D001431:Bacteriological Techniques; D002512:Cephalothin / Q000627:therapeutic use; D002648:Child; D002701:Chloramphenicol / Q000627:therapeutic use; D003023:Cloxacillin / Q000627:therapeutic use; D003967:Diarrhea / Q000139:chemically induced; D004802:Eosinophilia / Q000139:chemically induced; D004917:Erythromycin / Q000627:therapeutic use; D006193:Haemophilus influenzae / Q000302:isolation & purification; D006801:Humans; D008712:Methicillin / Q000627:therapeutic use; D009325:Nausea / Q000139:chemically induced; D010400:Penicillin G / Q000627:therapeutic use*; D010401:Penicillin G Benzathine / Q000627:therapeutic use; D010402:Penicillin G Procaine / Q000627:therapeutic use; D010404:Penicillin V / Q000627:therapeutic use; D010817:Physician-Patient Relations; D011537:Pruritus / Q000139:chemically induced; D012141:Respiratory Tract Infections / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology; D012871:Skin Diseases / Q000139:chemically induced; D013210:Staphylococcus / Q000302:isolation & purification; D013291:Streptococcus / Q000302:isolation & purification; D013296:Streptococcus pneumoniae / Q000302:isolation & purification; D013449:Sulfonamides / Q000627:therapeutic use; D013752:Tetracycline / Q000627:therapeutic use; D014581:Urticaria / Q000139:chemically induced; D014839:Vomiting / Q000139:chemically induced
D013449:Sulfonamides; D010402:Penicillin G Procaine; D004917:Erythromycin; D002701:Chloramphenicol; D000667:Ampicillin; D013752:Tetracycline; D003023:Cloxacillin; D010400:Penicillin G; D008712:Methicillin; D002512:Cephalothin; D010401:Penicillin G Benzathine; D010404:Penicillin V